| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1352458509107017 |
| P698 | PubMed publication ID | 19805441 |
| P2093 | author name string | Diego Cadavid | |
| Joan Skurnick | |||
| Soyeon Kim | |||
| Karolina Hankiewicz | |||
| Stuart D Cook | |||
| Leo J Wolansky | |||
| Eugene D Festa | |||
| P2860 | cites work | Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 |
| The mammalian host response to borrelia infection | Q22252691 | ||
| Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia | Q24322068 | ||
| Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis | Q24648404 | ||
| A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 | Q28263524 | ||
| B-cell depletion with rituximab in relapsing-remitting multiple sclerosis | Q28268626 | ||
| Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis | Q36454469 | ||
| Chemokines and chemokine receptors: multipurpose players in neuroinflammation. | Q36902281 | ||
| Relapsing fever borreliosis in interleukin-10-deficient mice | Q36974418 | ||
| High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae. | Q39020133 | ||
| Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection | Q40345834 | ||
| The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis | Q40414775 | ||
| Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. | Q40705789 | ||
| Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study | Q46091691 | ||
| Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis | Q48114462 | ||
| Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis | Q48399228 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Concurrent validity of the MS Functional Composite using MRI as a biological disease marker | Q49068813 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling. | Q53566540 | ||
| P433 | issue | 11 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 1271-1279 | |
| P577 | publication date | 2009-10-05 | |
| P1433 | published in | Multiple Sclerosis Journal | Q1952449 |
| P1476 | title | Serum levels of CXCL13 are elevated in active multiple sclerosis | |
| P478 | volume | 15 |
| Q38018052 | B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms |
| Q52368904 | Biomarkers in Multiple Sclerosis. |
| Q35364112 | Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel |
| Q38984981 | Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases |
| Q35078327 | Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future |
| Q39148044 | Brain inflammation is accompanied by peripheral inflammation in Cstb (-/-) mice, a model for progressive myoclonus epilepsy. |
| Q47581475 | CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients. |
| Q39808939 | Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. |
| Q51359685 | Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis. |
| Q92669017 | Chronic inflammation in multiple sclerosis - seeing what was always there |
| Q36920466 | Circulating T follicular helper cells with increased function during chronic graft-versus-host disease |
| Q34168761 | Deletion of mitochondrial uncoupling protein-2 increases ischemic brain damage after transient focal ischemia by altering gene expression patterns and enhancing inflammatory cytokines |
| Q33867548 | Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease |
| Q33562130 | Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission |
| Q37729523 | Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse |
| Q57810320 | Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis |
| Q38029187 | Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy |
| Q36476035 | Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE. |
| Q36742625 | Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis |
| Q26770818 | Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis |
| Q28535303 | Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis |
| Q47638443 | Fluid biomarker and electrophysiological outcome measures for progressive MS trials |
| Q33758016 | IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection |
| Q35751484 | Impaired Cell Cycle Regulation in a Natural Equine Model of Asthma. |
| Q33886486 | Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload |
| Q34020894 | Lymphoid chemokines in the CNS. |
| Q52657141 | Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation. |
| Q37170453 | Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis |
| Q26852859 | Stage-specific immune dysregulation in multiple sclerosis |
| Q33654152 | The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). |
| Q37993033 | The evidence for a role of B cells in multiple sclerosis |
Search more.